Medically reviewed on Nov 15, Excipient information presented when available limited, particularly for generics uses for carafate consult specific product labeling. Forms a complex by binding with positively charged proteins in exudates, forming a viscous paste-like, adhesive substance.
This selectively forms a protective coating that acts locally to protect uses for carafate 80 mg gastric lining against peptic acid, pepsin, and bile salts. Paste formation and ulcer adhesion: Peptic ulcer, adjunct therapy off-label use: Infants, Children, and Adolescents limited uses for carafate 80 mg available: There are no dosage adjustments provided in the manufacturer's labeling. Aluminum salt is minimally uses for carafate however, may accumulate in renal impairment; use see more caution in patients with chronic renal failure or on dialysis.
Add eight 1 uses for carafate tablets to a mL glass bottle.
In a separate container, dissolve 2 flavor packets Vari-Flavors; Ross Laboratories with 10 mL uses for carafate 80 mg water, and swirl until dissolved then add to uses for carafate mixture. Label "shake well" for esophagitis motilium diarrhea "refrigerate".
Use within 2 weeks. Administer on an empty stomach. Shake suspension well before use.
Do not administer antacids within 30 minutes of administration of sucralfate. Sucralfate may decrease the serum concentration of Bictegravir. Administer bictegravir, emtricitabine, and tenofovir alafenamide under fasting conditions at least 2 hours before sucralfate.
Sucralfate may decrease the absorption of Cholic Acid. Sucralfate may decrease the serum concentration of Digoxin. Specifically, sucralfate may decrease the absorption of uses for carafate. Administer digoxin at least 2 hours before or at least 6 hours after sucralfate. Sucralfate may decrease the serum concentration of Dolutegravir.
Administer dolutegravir at least 2 hours uses for carafate 80 mg or 6 hours after sucralfate.
Sucralfate may decrease the serum concentration of Eltrombopag. Administer eltrombopag at least 2 hours before or 4 hours after oral administration of sucralfate. Sucralfate may decrease the serum concentration of Furosemide. Sucralfate may impair the absorption of furosemide. Avoid concomitant oral administration of furosemide and sucralfate. Separate administration by at least 2 hours. Does not apply uses for carafate 80 mg parenterally administered furosemide.
Sucralfate may decrease the serum concentration of Ketoconazole Systemic. Sucralfate may decrease the serum concentration of Levothyroxine. May increase the serum concentration of Sucralfate.
Specifically, the absorption of aluminum may be increased. More specifically, sucralfate may impair the absorption of fluoride.
Avoid administration of aluminum-containing uses for carafate 80 mg, such as sucralfate, within at least hours of fluoride administration. In patients with severe renal dysfunction, consider avoiding this uses for carafate altogether.
Specifically, the absorption of aluminum from sucralfate may be increased, leading to an increase in the serum aluminum concentration. Sucralfate may decrease the absorption of Phosphate Supplements.
This applies only to oral phosphate administration. Administering oral uses for carafate supplements at least 1 hour before or 2 hours after administration carafate sucralfate may reduce the significance uses for the interaction. Sucralfate may decrease the serum concentration of QuiNIDine.
2018 ©